Concomitant thyroid MALT lymphoma and papillary thyroid carcinoma;Concomitância de linfoma MALT de tireoide e carcinoma papilífero de tireoide

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 54, Issue 4, 2010, Pages 425-428

  de Melo, Giulianno Molina ^a   Sguilar, Danilo Anunciatto ^a   Petiti, Cyntia Moniz Figueira ^a   Eichstaedt, André Gustavo Gumz ^a   Caiado, Rogério Ramos ^a   Souza, Ricardo Antenor de Souza e ^a  

^a HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956450231     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302010000400013     Document Type: Article

References (19)

1. Lam KY, Chung LY, Kwong DLW, Lee J, Srivastava G. Malignant lymphoma of the thyroid: a 30-year clinicopathological experience and an evaluation of the presence of Epstein-Barr virus. Am J Clin Pathol. 1999;112:263-70.
2. Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol. 1999;26:316-23.
3. Nakao A, Fukuoka T, Hibi K. Mucosa-associated lymphoid tissue (MALT) lymphoma of the thyroid: report of a case. Anticancer Res. 1999;19(1B):811-4.
4. Yamamoto Y, Maeda T, Izumi K, et al. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer. 1990;65:1173-9.
5. Correa P, Chen VW. Endocrine gland cancer. Cancer. 1995;75:338-52.
6. DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414-24.
7. Mack LA, Pasieka JL. An evidence-based approach to the treatment of thyroid lymphoma. World J Surg. 2007;31(5):978-86.
8. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947-53.
9. Sebastian SO, Gonzales RJM. Papillary thyroid carcinoma. Prognostic index for survival including the histological variety. Arch Surg. 2000;135:272-7.
10. Earnest LM, Cooper DS, Sciubba JJ, Tufano RP. Thyroid MALT lymphoma in patients with a compressive goiter. Head Neck. 2006;28:765-70.
11. Matsuzuka F, Miyauchi A, Katayama S. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid. 1993;3:93-9.
12. Harris N, Jaffe E, Stein H, Banks P, Chan J, Cleary M, Delsol G, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-92.
13. Wang SA, Rahemtullah A, Faquin WC, Roepke J, Harris NL, Hasserjian RP. Hodgkin's lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature. Mod Pathol. 2005;18:1577-84.
14. Thieblemont C, Mayer A, Dumontet C, Barbier Y, Callet-Bauchu E, Felman P, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab. 2002;87:105-11.
15. Carbone P, Kaplan H, Musshof K, Smithers D, Tubiana M. Report on the Committee on Hodgkin's disease staging classification. Cancer Res. 1971;31:1860-1.
16. Belal AA, Allam A, Kandil A, El Husseiny G, Khafaga Y, Al Rajhi N, et al. Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma. Am J Clin Oncol. 2001;24:299-305.
17. Vigliotti A, Kong JS, Fuller LM. Thyroid lymphomas stage IE and IIE: comparative results for radiotherapy only, combination chemotherapy only, and multimodality treatment. Int J Radiat Oncol Phys. 1986;12(10):1807-12.
18. Niitsu N, Okamoto M, Nakamura N, Nakamine H, Bessho M, Hirano M. Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma. Ann Oncol. 2007;18(7):1203-8.
19. Brepoels L, Stroobants S. PET scanning and prognosis in Hodgkin's lymphoma. Curr Opin Oncol. 2008;20(5):509-16.